Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China.

Vabysmo (faricimab-svoa) - Roche

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

http://www.ncbi.nlm.nih.gov/pubmed/41847948

Christian Buehrer; Fenghao Shi; Sheng Han; Shuhua Tan; Tianyi Liu; Yamin Shu; Yan Xia

Mar 18, 2026